The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
COSTEM 2023 | IFM-2015-03: plerixafor before salvage ASCT in R/R myeloma
Christian Chabannon, MD, PhD, Institut Paoli Calmettes, Marseille, France, discusses the use of plerixafor before salvage autologous stem cell transplantation (ASCT) in patients with relapsed/refractory (R/R) multiple myeloma. This interview took place at The 8th Congress on Controversies in Stem Cell Transplantation and Cellular Therapies (COSTEM 2023), held in Berlin, Germany.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
